April 2018

Assess catabolic stability of biologics & ADCs with Lysosomes – Characterized test systems

Author: Isabelle Nobiron, tebu-bio Posted: 30 April 2018

A post from our EU partner, tebu-bio, on the characterization of isolated human liver lysosomes, and validating them as test systems for in vitro assessment of catabolic stability of biologics drugs entering the cell by the endosomal–lysosomal pathway...

Read more

No More Water Baths! Simplify Hepatocyte Thaws and Eliminate Contamination

Author: Dr. Chris Bohl, Michael Millhollen Posted: 03 April 2018

By eliminating the need for water baths, a significant source of tissue culture contamination can be removed, efficiency is increased and performance variability is decreased...

Read more

Sekisui XenoTech Adds US and Japanese Support for MATE1 and MATE2-K Drug Transporter Studies

Author: Michael Millhollen Posted: 02 April 2018

Sekisui XenoTech now offers MATE1 and MATE2-K drug transporter evaluation services at our research labs in the USA as well as Japan!

Read more

Sekisui Medical Celebrates its 10th Anniversary

Author: Michael Millhollen Posted: 01 April 2018

It's been 10 years since Sekisui Medical Co., Ltd. was established, the same year XenoTech, LLC was acquired...

Read more